Filing Details

Accession Number:
0001045309-19-000037
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-06 16:23:43
Reporting Period:
2019-05-03
Accepted Time:
2019-05-06 16:23:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1045309 W R Grace & Co GRA Chemicals & Allied Products (2800) 650773649
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325901 A Mark Shelnitz C/O W. R. Grace &Amp; Co.
7500 Grace Drive
Columbia MD 21044
Sr. Vp, Gc And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2019-05-03 11,792 $74.70 76,253 No 4 M Direct
Common Stock, Par Value $0.01 Per Share Disposition 2019-05-03 11,792 $76.36 64,461 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (rights to buy) Disposition 2019-05-03 11,792 $0.00 11,792 $74.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-05-08 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $.01 Per Share 12,144 Indirect By Trust
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.35 to $76.41, inclusive. The reporting person undertakes to provide W. R. Grace & Co., any security holder of W. R. Grace & Co., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. Such shares are held in a trust established by the issuer for the benefit of certain officers and directors.
  3. Options became exercisable in three substantially equal annual installments beginning on May 8, 2015.